Bradley Merrill Thompson

Healthcare professionals other than physicians, dentists and veterinarians who have prescribing authority under state law can order prescription digital therapeutics. That could improve access, especially to devices that treat mental health conditions.

Epstein Becker & Green's Bradley Merrill Thompson describes the agency's current trajectory for regulation of patient-facing and provider-facing telehealth products that incorporate AI.

Ironically, the agency that goes after companies for false and misleading claims is making them about its own policies.

While key details are still missing, the picture that's emerging is surprisingly restrictive

Epstein Becker & Green's Bradley Merrill Thompson says the FDA's much-touted program is riddled with unseen costs and unanswered questions.

About the Author: Bradley Merrill Thompson is a member of the firm at Epstein Becker & Green, P.